Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease

Paul Michael Grossman, Farrell Mendelsohn, Timothy D. Henry, James B. Hermiller, Marc Litt, Jorge F. Saucedo, Robert J. Weiss, David E. Kandzari, Neal Kleiman, R. David Anderson, Daniel Gottlieb, Ronald Karlsberg, Jeffery Snell, Krishna Rocha-Singh

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease'. Together they form a unique fingerprint.

Medicine & Life Sciences